Supplementary file.pdf (409.64 kB)

Targeting CD47 enhanced the antitumor immunity of PD-L1 blockade in B-cell lymphoma. Supplementary figures

figure

posted on 2023-02-02, 07:55 authored by Dianwen Ju, Xunlong Shi, Li Ye, Jiajun Fan, Xian Zeng, Zeguo Zhu, Zhonglian Cao, Wei Chen, Xiaozhi Hu, Jingyun Luan, Lei Han, Yichen Wang, Caili Xu, Shaofei Wang, Xuyao Zhang, Yanyang Nan

Supplementary figures 1-3

History

Usage metrics

Keywords

PD-L1 immune checkpoint inhibitors combination therapy CD47 B-cell lymphoma

Licence

CC BY-NC-ND 4.0

Targeting CD47 enhanced the antitumor immunity of PD-L1 blockade in B-cell lymphoma. Supplementary figures

History

Usage metrics

Categories

Keywords

Licence

Exports